Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer-Reference-Cited by-同舟云学术

Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer

Published:2014-03-03 Issue:11 Volume:111 Page:4251-4256
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Wang S.,Kollipara R. K.,Srivastava N.,Li R.,Ravindranathan P.,Hernandez E.,Freeman E.,Humphries C. G.,Kapur P.,Lotan Y.,Fazli L.,Gleave M. E.,Plymate S. R.,Raj G. V.,Hsieh J.-T.,Kittler R.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference25 articles.

1. Cancer statistics, 2012

2. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

3. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

4. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort

5. Reactivation of Androgen Receptor–Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The deubiquitinase USP9X regulates RIT1 protein abundance and oncogenic phenotypes;iScience;2024-08

2. Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-05

3. USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway;Cell Death & Disease;2024-03-26

4. The deubiquitinase USP9X regulates RIT1 protein abundance and oncogenic phenotypes;2023-12-01

5. Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy;Frontiers in Immunology;2023-07-24